<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Rexahn Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing innovative therapeutics for the treatment of cancer. Rexahn currently has two clinical stage oncology candidates, RX-3117 and RX-5902 (Supinoxin™), and additional compounds in preclinical development to treat multiple types of cancer. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas J. Swirsky
    • FOUNDED
      2001
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    China SXT Pharmaceuticals, Inc.

    China SXT Pharmaceuticals, Inc.

    China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company based in T...

    China SXT Pharmaceuticals, Inc. is an innovativ...

    Filing Type:    PU
    CAVU Biotherapies, Inc.

    CAVU Biotherapies, Inc.

    CAVU Biotherapies offers a comprehensive solution to prepare for, monitor, and tre...

    CAVU Biotherapies offers a comprehensive soluti...

    Filing Type:    CF
    GW Pharmaceuticals Plc

    GW Pharmaceuticals Plc

    Founded in 1998, GW is a biopharmaceutical company focused on discovering, develop...

    Founded in 1998, GW is a biopharmaceutical comp...

    Filing Type:    PU
    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals, Inc.

    Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on...

    Deciphera Pharmaceuticals is a clinical-stage b...

    Filing Type:    PU
    Athenex, Inc.

    Athenex, Inc.

    Athenex is a global oncology focused biopharmaceutical company dedicated to the di...

    Athenex is a global oncology focused biopharmac...

    Filing Type:    PU
    UroGen Pharma Ltd.

    UroGen Pharma Ltd.

    UroGen Pharma Ltd. is a clinical-stage biopharmaceutical company developing advanc...

    UroGen Pharma Ltd. is a clinical-stage biopharm...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.